Eosinophilic fasciitis: From pathophysiology to treatment

被引:51
|
作者
Ihn, Hironobu [1 ]
机构
[1] Kumamoto Univ, Fac Life Sci, Dept Dermatol & Plast Surg, 1-1-1 Honjo, Kumamoto 8608556, Japan
关键词
Cytokines; Eosinophilia; Fibrosis; Hypergammaglobulinemia; Skin; SERUM-LEVELS; FIBROBLASTS; SCLERODERMA; EXPRESSION; PATIENT; MORPHEA; LEVEL;
D O I
10.1016/j.alit.2019.03.001
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Eosinophilic fasciitis is a disease originally proposed as "diffuse fasciitis with eosinophilia" by Shulman in 1974. The patients with this disease often have history of strenuous exercise or labor a few days to 1-2 weeks before the onset. The chief symptoms are symmetrical, full-circumference swelling and plate-like hardness of the distal limbs. This is accompanied by redness and pain in the early stages, with many cases exhibiting systemic symptoms such as fever or generalized fatigue. The lesions have been observed extending to the proximal limbs, though never on the face or fingers. En bloc biopsies from the skin to the fascia show marked fascial thickening and inflammatory cell infiltration by the lymphocytes and plasma cells. Eosinophilic infiltration is useful for the diagnosis but is only seen in the early stages of the disease. Recently, "Diagnostic criteria, severity classification, and clinical guidelines for eosinophilic fasciitis" were published. This review article discusses about eosinophilic faciitis in detail, from its pathophysiology to the treatment. Copyright (C) 2019, Japanese Society of Allergology. Production and hosting by Elsevier B.V.
引用
收藏
页码:437 / 439
页数:3
相关论文
共 50 条
  • [1] Eosinophilic fasciitis: From pathophysiology to therapeutics
    Knapp, S.
    Bolko, L.
    Servettaz, A.
    Didier, K.
    REVUE DE MEDECINE INTERNE, 2024, 45 (08): : 488 - 497
  • [2] Treatment and Monitoring of Eosinophilic Fasciitis
    Selva-O'Callaghan, Albert
    Trallero-Araguas, Ernesto
    Gil-Vila, Albert
    Guillen-Del Castillo, Alfredo
    Matas-Garcia, Ana
    Milisenda, Jose Cesar
    Simeon-Aznar, Carmen Pilar
    Pinal-Fernandez, Iago
    CURRENT TREATMENT OPTIONS IN RHEUMATOLOGY, 2025, 11 (01)
  • [3] Eosinophilic Fasciitis in a Pediatric Patient
    Loupasakis, Konstantinos
    Derk, Chris T.
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2010, 16 (03) : 129 - 131
  • [4] Treatment of Eosinophilic Fasciitis With Sirolimus
    Oza, Vikash S.
    Walsh, Rabina
    North, Jeffrey
    Berger, Timothy G.
    Murase, Jenny E.
    JAMA DERMATOLOGY, 2016, 152 (04) : 488 - 490
  • [5] Eosinophilic fasciitis
    Lamback, Elisa Baranski
    Seabra Resende, Fernanda Simoes
    Rocha Lenzi, Thiara Cristina
    ANAIS BRASILEIROS DE DERMATOLOGIA, 2016, 91 (05) : 57 - 59
  • [6] Eosinophilic Fasciitis: an Updated Review on Diagnosis and Treatment
    Mazori, Daniel R.
    Femia, Alisa N.
    Vleugels, Ruth Ann
    CURRENT RHEUMATOLOGY REPORTS, 2017, 19 (12)
  • [7] EOSINOPHILIC FASCIITIS WITH SUBJACENT MYOSITIS
    Whitlock, Julia B.
    Dimberg, Elliot L.
    Selcen, Duygu
    Rubin, Devon I.
    MUSCLE & NERVE, 2017, 56 (03) : 525 - 529
  • [8] Eosinophilic fasciitis
    Niklas, Karolina
    Niklas, Arkadiusz
    Puszczewicz, Mariusz
    POSTEPY HIGIENY I MEDYCYNY DOSWIADCZALNEJ, 2015, 69 : 488 - 495
  • [9] Diagnostic criteria, severity classification and guidelines of eosinophilic fasciitis
    Jinnin, Masatoshi
    Yamamoto, Toshiyuki
    Asano, Yoshihide
    Ishikawa, Osamu
    Sato, Shinichi
    Takehara, Kazuhiko
    Hasegawa, Minoru
    Fujimoto, Manabu
    Ihn, Hironobu
    JOURNAL OF DERMATOLOGY, 2018, 45 (08) : 881 - 890
  • [10] The use of tocilizumab in the treatment of refractory eosinophilic fasciitis: a case-based review
    Vilchez-Oya, Francisco
    Sanchez-Schmidt, Julia Maria
    Agusti, Anna
    Pros, Ana
    CLINICAL RHEUMATOLOGY, 2020, 39 (05) : 1693 - 1698